Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00976131 · ClinicalTrials.gov registry record · Phase 1
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
A Phase 1 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT00976131 is a Phase 1 study that has completed, run by Columbia University. The registered enrollment target is 7 participants.
The verdict
NCT00976131, a Phase 1 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This research study hopes to examine the effects of Coenzyme Q10 on doxorubicin (Adriamycin) metabolism during breast cancer treatment.
Interventions
- DRUG Cyclophosphamide
- DRUG Doxorubicin
- DRUG CoQ10
- OTHER CoQ10 Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-09 |
| Est. Completion | 2021-01-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00976131
The ClinicalTrials.gov registry entry for NCT00976131 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cyclophosphamide is the first listed.
NCT00976131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00976131 about?
NCT00976131 is a clinical study titled "Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer". This research study hopes to examine the effects of Coenzyme Q10 on doxorubicin (Adriamycin) metabolism during breast cancer treatment.
What is the current status of trial NCT00976131?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2009-09. Estimated completion is 2021-01-20.
What interventions are being tested in trial NCT00976131?
The interventions under investigation include: Cyclophosphamide (DRUG), Doxorubicin (DRUG), CoQ10 (DRUG), CoQ10 Placebo (OTHER).
Who is sponsoring clinical trial NCT00976131?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.